After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

Mehmet Oz is pledging to divest from a broad portfolio of health care stocks if he is confirmed as President Trump’s pick to ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.

Powhatan will be represented at the Class 4 State Track and Field Championships by Eli Wagner, who qualified with a third place jump at the regional championship.

Raridon has struggled to get his explosiveness back, and the injuries limited his reps during the first two seasons of his ...

The four-member Pro Football Hall of Fame Class of 2025 was revealed on Thursday night at NFL Honors, and two-time Super Bowl MVP Eli Manning was not included. In his first year on the HOF ballot ...

BOSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel ...

Mike Czapar-- Senior Vice President, Investor Relations Good morning. Thank you for joining us for Eli Lilly and Company's Q4 2024 earnings call. I'm Mike Czapar, senior vice president of investor ...

Chris Schott, JPMorgan, questioned the broad study scope for Orforglipron ... as opportunities to showcase product differentiation. Eli Lilly ended 2024 on a strong note, with 45% revenue growth ...

As shown in the Eli Lilly 11, we combine U.S. Incretin Analogs ... are looking for some single events that will trigger the broad reimbursement or not. And I don't think we've ever really thought ...

Both Novo Nordisk and Eli Lilly's current weight loss treatments ... receive regularly approval by early 2026. "We have a really broad portfolio of different, say, biologies — also both ...